IRIDEX Corporation (IRIX)
IRIX Stock Price Chart
Explore IRIDEX Corporation interactive price chart. Choose custom timeframes to analyze IRIX price movements and trends.
IRIX Company Profile
Discover essential business fundamentals and corporate details for IRIDEX Corporation (IRIX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
16 Feb 1996
Employees
93.00
Website
https://www.iridex.comCEO
Patrick Mercer
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
IRIX Financial Timeline
Browse a chronological timeline of IRIDEX Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 11 Nov 2025
Earnings released on 12 Aug 2025
EPS came in at -$0.06 surpassing the estimated -$0.09 by +33.33%, while revenue for the quarter reached $13.57M , beating expectations by +3.60%.
Earnings released on 13 May 2025
EPS came in at -$0.10 matching the estimated -$0.10, while revenue for the quarter reached $11.90M , missing expectations by -1.69%.
Earnings released on 27 Mar 2025
EPS came in at -$0.05 matching the estimated -$0.05, while revenue for the quarter reached $12.70M , missing expectations by -0.81%.
Earnings released on 12 Nov 2024
EPS came in at -$0.12 falling short of the estimated -$0.09 by -33.33%, while revenue for the quarter reached $11.58M , missing expectations by -7.35%.
Earnings released on 8 Aug 2024
EPS came in at -$0.16 falling short of the estimated -$0.12 by -33.33%, while revenue for the quarter reached $12.63M , beating expectations by +0.25%.
Earnings released on 14 May 2024
EPS came in at -$0.21 falling short of the estimated -$0.12 by -75.00%, while revenue for the quarter reached $11.76M , missing expectations by -1.99%.
Earnings released on 26 Mar 2024
EPS came in at -$0.18 falling short of the estimated -$0.05 by -260.00%, while revenue for the quarter reached $12.46M , missing expectations by -16.39%.
Earnings released on 14 Nov 2023
EPS came in at -$0.11 surpassing the estimated -$0.13 by +15.38%, while revenue for the quarter reached $12.85M , missing expectations by -10.45%.
Earnings released on 10 Aug 2023
EPS came in at -$0.17 falling short of the estimated -$0.11 by -54.55%, while revenue for the quarter reached $12.86M , missing expectations by -9.66%.
Earnings released on 11 May 2023
EPS came in at -$0.13 falling short of the estimated -$0.12 by -8.33%, while revenue for the quarter reached $13.71M , missing expectations by -4.55%.
Earnings released on 9 Mar 2023
EPS came in at -$0.07 surpassing the estimated -$0.11 by +36.36%, while revenue for the quarter reached $15.20M , beating expectations by +0.23%.
Earnings released on 10 Nov 2022
EPS came in at -$0.11 surpassing the estimated -$0.15 by +26.67%, while revenue for the quarter reached $14.64M , beating expectations by +5.54%.
Earnings released on 15 Aug 2022
EPS came in at -$0.14 surpassing the estimated -$0.16 by +12.50%, while revenue for the quarter reached $13.76M , missing expectations by -1.22%.
Earnings released on 12 May 2022
EPS came in at -$0.15 surpassing the estimated -$0.16 by +6.25%, while revenue for the quarter reached $13.39M , missing expectations by -0.21%.
Earnings released on 10 Mar 2022
EPS came in at -$0.15 falling short of the estimated -$0.11 by -36.36%, while revenue for the quarter reached $15.25M , beating expectations by +3.85%.
Earnings released on 11 Nov 2021
EPS came in at -$0.14 surpassing the estimated -$0.15 by +6.67%, while revenue for the quarter reached $13.26M , missing expectations by -6.25%.
Earnings released on 12 Aug 2021
EPS came in at -$0.09 surpassing the estimated -$0.16 by +43.75%, while revenue for the quarter reached $13.43M , meeting expectations.
Earnings released on 11 May 2021
EPS came in at -$0.14 matching the estimated -$0.14, while revenue for the quarter reached $11.96M , beating expectations by +27.09%.
Earnings released on 22 Mar 2021
EPS came in at -$0.01 surpassing the estimated -$0.11 by +90.91%, while revenue for the quarter reached $12.30M .
Earnings released on 9 Nov 2020
EPS came in at -$0.12 surpassing the estimated -$0.18 by +33.33%, while revenue for the quarter reached $8.80M , missing expectations by -22.73%.
IRIX Stock Performance
Access detailed IRIX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.